Product Information

PITAVASTATIN 4 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $1.1362 per EA under NDC 72603048001. Its NADAC has been published 69 times since Apr 30, 2025.

FDA first approved this application on Apr 30, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the pitavastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for PITAVASTATIN 4 MG TABLET has been published 69 times since Apr 30, 2025, and over the history we have for it it has declined 31.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.